XML 25 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings (Accumulated Deficit)
Adjustment
Adjustment
Additional Paid-In Capital
Adjustment
Retained Earnings (Accumulated Deficit)
Beginning Balance, shares outstanding (in shares) at Dec. 31, 2020   135,030            
Beginning Balance at Dec. 31, 2020 $ 151,047 $ 135 $ 625,483 $ 22 $ (474,593) $ (52,564) $ (65,535) $ 12,971
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation expense 20,820   20,820          
Issuance of common stock for the conversion of 2024 Convertible Notes (shares)   9,083            
Issuance of common stock for the conversion of 2024 Convertible Notes 13,104 $ 9 13,095          
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock and performance stock units, net and shares issued under the ESPP plan (in shares)   1,497            
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock and performance stock units, net and shares issued under the ESPP plan 12,536 $ 2 12,534          
Repurchase of common stock (in shares)   (8,112)            
Repurchase of common stock (350,058) $ (8) (350,050)          
Other comprehensive income (loss) (642)     (642)        
Net income 402,710              
Ending Balance, shares outstanding (in shares) at Dec. 31, 2021   137,498            
Ending Balance at Dec. 31, 2021 196,953 $ 138 256,347 (620) (58,912)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation expense 24,397   24,397          
Issuance of common stock for the conversion of 2024 Convertible Notes (shares)   1,512            
Issuance of common stock for the conversion of 2024 Convertible Notes 1,693 $ 1 1,692          
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock and performance stock units, net and shares issued under the ESPP plan (in shares)   1,077            
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock and performance stock units, net and shares issued under the ESPP plan 14,050 $ 1 14,049          
Capped call transaction (69,120)   (69,120)          
Repurchase of common stock (in shares)   (4,933)            
Repurchase of common stock (200,002) $ (5) (199,997)          
Other comprehensive income (loss) (302)     (302)        
Net income 202,129       202,129      
Ending Balance, shares outstanding (in shares) at Dec. 31, 2022   135,154            
Ending Balance at Dec. 31, 2022 169,798 $ 135 27,368 (922) 143,217      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation expense 36,620   36,620          
Issuance of common stock for the conversion of 2024 Convertible Notes (shares)   289            
Issuance of common stock for the conversion of 2024 Convertible Notes (126) $ 0 (126)          
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock and performance stock units, net and shares issued under the ESPP plan (in shares)   945            
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock and performance stock units, net and shares issued under the ESPP plan 7,879 $ 2 7,877          
Repurchase of common stock (in shares)   (9,618)            
Repurchase of common stock (403,601) $ (10) (69,330)   (334,261)      
Other comprehensive income (loss) (8,356)     (8,356)        
Net income 281,594       281,594      
Ending Balance, shares outstanding (in shares) at Dec. 31, 2023   126,770            
Ending Balance at Dec. 31, 2023 $ 83,808 $ 127 $ 2,409 $ (9,278) $ 90,550